Workflow
APx Acquisition I(APXI)
icon
Search documents
APx Acquisition I(APXI) - 2022 Q3 - Quarterly Report
2022-11-13 16:00
Financial Performance - For the three months ended September 30, 2022, the Company reported a net income of $548,031, which included $462,704 in interest income and a $249,047 gain on settlement of deferred underwriting fees [124]. - For the nine months ended September 30, 2022, the net income was $10,891,420, comprising $722,006 in interest income and $10,826,200 in unrealized gains on fair value changes of warrants [125]. - As of September 30, 2022, the Company had $528,263 in its operating bank account and a working capital deficit of $12,870 [127]. IPO and Capital Structure - The Company generated gross proceeds of $172.5 million from the IPO, selling 17,250,000 units at $10.00 per unit, including 2,250,000 units from the underwriters' over-allotment option [119]. - The Company placed $175.95 million from the IPO and Private Placement Warrants proceeds in a Trust Account, invested only in U.S. government securities [121]. - The underwriters waived their right to a deferred fee of approximately $6.04 million, resulting in a gain from settlement of deferred underwriting commissions [122]. Business Combination and Future Plans - The Company has until March 9, 2023, to consummate a Business Combination, after which a mandatory liquidation may occur if not completed [130]. - The Company has not selected any specific business combination target and has not engaged in substantive discussions regarding an initial business combination [118]. - The Company may need to obtain alternative liquidity and capital resources to meet its needs, which may not be available [129]. Regulatory and Accounting Considerations - The Company is assessing the impact of ASU 2020-06 on its financial position, results of operations, or cash flows, effective for fiscal years beginning after December 15, 2023 [143]. - Management does not believe that any recently issued accounting pronouncements will have a material effect on the Company's financial statements [144]. - The Company qualifies as an "emerging growth company" under the JOBS Act, allowing it to delay the adoption of new or revised accounting standards [145]. - The Company is evaluating the benefits of relying on reduced reporting requirements provided by the JOBS Act, which may exempt it from certain disclosures for five years [146]. - The Company is classified as a smaller reporting company and is not required to provide certain market risk disclosures [147]. Expense Expectations - The Company expects to incur increased expenses due to being a public company, including legal and financial reporting costs, and anticipates substantial increases in expenses after this period [123].
APx Acquisition I(APXI) - 2022 Q2 - Quarterly Report
2022-08-31 16:00
Financial Performance - For the three months ended June 30, 2022, the Company reported a net income of $2,682,422, which included $245,587 in interest income and a $2,636,250 unrealized gain on fair value changes of warrants [125]. - For the six months ended June 30, 2022, the net income was $10,343,389, comprising $259,302 in interest income and a $10,650,450 unrealized gain on fair value changes of warrants [126]. - As of June 30, 2022, the Company had $665,774 in its operating bank account and working capital of $289,100 [128]. IPO and Capital Structure - The Company generated gross proceeds of $172.5 million from the IPO, selling 17,250,000 units at $10.00 per unit, including 2,250,000 units from the underwriters' over-allotment option [120]. - The underwriters received a cash underwriting discount of $3.45 million and a deferred fee of $6.04 million, payable upon completion of an initial business combination [123]. - The Company placed $175.95 million from the IPO and Private Placement Warrants proceeds into a Trust Account, invested in U.S. government securities [122]. Business Combination and Strategy - The Company has until March 9, 2023, to consummate a Business Combination, after which a mandatory liquidation may occur if not completed [131]. - The Company intends to focus its search for a business combination on companies in a Spanish-speaking market or those providing goods and services to such markets [119]. Regulatory and Accounting Matters - The Financial Accounting Standards Board issued ASU 2020-06 to simplify accounting for certain financial instruments, effective January 1, 2022 [144]. - The company is assessing the impact of ASU 2020-06 on its financial position, results of operations, or cash flows [144]. - The company qualifies as an "emerging growth company" under the JOBS Act, allowing it to delay the adoption of new accounting standards [146]. - The company may not be required to provide certain disclosures and reports under the JOBS Act for a period of five years or until it is no longer an "emerging growth company" [147]. - The company is evaluating the benefits of relying on reduced reporting requirements provided by the JOBS Act [147]. - The company is classified as a smaller reporting company and is not required to provide certain market risk disclosures [148]. Expenses and Reimbursements - The Company expects to incur increased expenses due to being a public company, including legal, financial reporting, and due diligence costs [124]. - The Company may reimburse the Sponsor up to $10,000 per month for administrative services until the completion of the initial business combination or liquidation [132].
APx Acquisition I(APXI) - 2022 Q1 - Quarterly Report
2022-05-15 16:00
Financial Performance - For the three months ended March 31, 2022, the Company reported a net income of $7,660,967, which included $8,014,200 of unrealized gains on fair value changes of warrants [113]. - As of March 31, 2022, the Company had $792,547 in its operating bank account and working capital of $451,014 [114]. IPO and Fundraising - The Company generated gross proceeds of $172.5 million from the IPO, selling 17,250,000 units at $10.00 per unit, including 2,250,000 units from the underwriters' over-allotment option [107]. - The underwriters received a cash underwriting discount of $3.45 million, with an additional deferred fee of $6.04 million payable upon completion of a Business Combination [111]. - The Company placed $175.95 million from the IPO and Private Placement Warrants proceeds into a Trust Account, which will be invested in U.S. government securities [110]. Business Combination Plans - The Company has until March 9, 2023, to consummate a Business Combination, after which a mandatory liquidation may occur if not completed [116]. - The Company intends to focus its search for a business combination on companies in the SSLA or those providing goods and services to Spanish-speaking markets [106]. - The Company has not yet selected a specific business combination target and has not engaged in substantive discussions with any potential targets [106]. Public Company Status - The Company expects to incur increased expenses due to being a public company, including legal and financial reporting costs, and anticipates these expenses will increase substantially after this period [112]. - The company qualifies as an "emerging growth company" under the JOBS Act, allowing it to delay the adoption of new or revised accounting standards [130]. - The company is evaluating the benefits of reduced reporting requirements under the JOBS Act, which may exempt it from certain disclosures for five years or until it no longer qualifies as an "emerging growth company" [131]. - As a smaller reporting company, the company is not required to provide certain market risk disclosures as defined by Rule 12b-2 of the Exchange Act [132]. Administrative Services - The Company may reimburse the Sponsor up to $10,000 per month for administrative services until the completion of the initial business combination or liquidation [117].
APx Acquisition I(APXI) - 2021 Q4 - Annual Report
2022-04-07 16:00
IPO and Financial Proceeds - The company completed its Initial Public Offering (IPO) on December 9, 2021, raising gross proceeds of $172.5 million from the sale of 17,250,000 units at $10.00 per unit[259]. - Following the IPO, approximately $169.05 million from the net proceeds was placed in a Trust Account, which will be invested in U.S. government securities[261]. - The company incurred a total underwriting discount of $3.45 million at the IPO closing, with an additional deferred fee of $6.04 million payable upon completion of a business combination[262]. Financial Position and Performance - As of December 31, 2021, the company had cash of approximately $953,432 and current liabilities of $322,969, indicating a working capital of approximately $0.8 million[270]. - The company reported a net income of approximately $1.66 million for the period from inception through December 31, 2021, primarily due to non-operating gains from changes in fair value of derivative warrant liabilities[271]. - The company reported a net income (loss) per ordinary share, with diluted net income (loss) per share being the same as basic net income (loss) per share for the year ended December 31, 2021[286]. Business Combination and Future Plans - The company has until March 9, 2023, to complete a business combination, after which a mandatory liquidation will occur if not completed[276]. - The company plans to use its funds for identifying and evaluating prospective business combination candidates and related transaction costs[274]. - The company has not yet selected a specific business combination target but intends to focus on companies providing goods and services to Spanish-speaking markets[259]. Shareholder and Equity Information - The company’s sponsor purchased 8,950,000 private placement warrants at $1.00 each, which are exercisable at $11.50 per share[260]. - The company will provide public shareholders the opportunity to redeem their shares for a pro rata portion of the Trust Account, initially valued at $10.00 per share[265]. - The company has two classes of shares, Class A and Class B, with income and losses shared pro rata between them[285]. - The company’s ordinary shares subject to possible redemption are presented at redemption value as temporary equity, reflecting certain redemption rights outside of the company's control[284]. Accounting and Reporting - The company is currently assessing the impact of ASU 2020-06 on its financial position, results of operations, or cash flows, effective January 1, 2022[288]. - The company does not believe that any recently issued accounting pronouncements would have a material effect on its financial statements[289]. - The company’s financial statements are prepared in accordance with generally accepted accounting principles in the United States[281]. - The company evaluates its estimates and judgments related to fair value and accrued expenses on an ongoing basis[280]. - The company’s accounting for warrants requires professional judgment and is assessed at the time of issuance and each subsequent quarterly period[282]. - The company is classified as a smaller reporting company and is not required to provide certain market risk disclosures[291].